Bioresponsive Functional Phenylboronic Acid-Based Delivery System as an Emerging Platform for Diabetic Therapy.

Ma, Qiong; Zhao, Xi; Shi, Anhua; Wu, Junzi

Ma, Qiong; Zhao, Xi; Shi, Anhua; Wu, Junzi.

Afiliação

Ma Q; The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan 650500, People's Republic of China.
Zhao X; The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan 650500, People's Republic of China.
Shi A; The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan 650500, People's Republic of China.
Wu J; The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan 650500, People's Republic of China.

Int J Nanomedicine ; 16: 297-314, 2021.

Article em En | MEDLINE | ID: mdl-33488074

Assuntos

Ácidos Borônicos/química; Diabetes Mellitus/tratamento farmacológico; Portadores de Fármacos/química; Hipoglicemiantes/farmacologia; Ácidos Borônicos/metabolismo; Diabetes Mellitus/metabolismo; Portadores de Fármacos/metabolismo; Seguimentos; Glucose/metabolismo; Humanos; Hipoglicemiantes/química; Hipoglicemiantes/uso terapêutico; Insulina/química; Insulina/farmacologia; Insulina/uso terapêutico

Palavras-chave

diabetes; glucose sensitive; phenylboronic acid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Borônicos / Portadores de Fármacos / Diabetes Mellitus / Hipoglicemiantes Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google